Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: RESILIENCE GOVERNMENT SERVICES, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-03-07 to 2028-01-05
Current total value of award: $8128140
Description: U.S. FOOD AND DRUG ADMINISTRATION (FDA) LICENSED MONOCLONAL ANTIBODY  COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE, CLINICAL DEVELOPMENT PHASE 3 STUDY